Home MarketAlbert David Ltd.

Albert David Ltd. Stock Info: As on 2017-11-24 15:57:51

Nse

361.20

37.65(11.64%)
Change%
52 Week Range
275.00
30.00
382.85
13.00
Open320.00
Day's Range258.84 - 388.26
Value Traded (in ₹ Cr.) 4.91

Bse

361.30

39.05(12.12%)
Change %
52 Week Range
276.00
15.00
381.70
29.00
Open325.00
Day's Range257.80 - 386.70
Value Traded (in ₹ Cr.) 1.73

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 3,475,514.00 60.90%
Mutual Funds/UTI 900.00 0.02%
FII 0.00 0.00%
Employee 0.00 0.00%
Public 1,681,910.00 29.47%
Government 0.00 0.00%
Others 289,420.00 5.07%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 0.52
Basic EPS (Rs.) 84.10
Cash EPS 99.86
BVPerShare Excl 239.75
Operating Revenue 564.53
PBDITPerShare 57.86
Dividend 5.50
NPPerShare 84.10
Current Ratio 2.01
Quick Ratio 1.37
PriceToBV 1.25
Earnings 0.28
PBDIT Margin 10.24
PBT Margin 19.55
NP Margin 14.89
Return On Assets 21.44
Retention Ratios 93.45
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 324.16
Total Expenses 301.94
EBITDA 33.02
PBT 63.02
PAT 48.00
Net Income 48.00
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 143.76
Total Expenses 136.50
EBITDA 2.69
PBT 47.32
PAT 38.83
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 5.71
Net worth 136.83
Investments 47.54
Total Liability 223.84
Total debt 20.23
Net block 49.45
Total Assets 223.84
Parameter Sep-16 (₹ Cr.) 6M % change
Total share capital 5.71
Net worth 102.01
Investments 16.50
Total Liability 198.80
Total debt 21.19
Net block 51.38
Total Assets 198.80
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

535.05 535.15 -0.02
525.05537

Abbott India Ltd.

4977.5 4858.7 2.45
4810.055049

Ajanta Pharma Ltd.

1329.2 1327.15 0.15
12301362.3

Alembic Ltd.

39.35 39.25 0.25
3940.45

Alembic Pharmaceuticals Ltd.

515.5 514.3 0.23
507.4525.45

Alkem Laboratories Ltd.

1987.9 1974.45 0.68
19442013.85

Alpa Laboratories Ltd.

32.35 32.3 0.15
30.333.5
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

56.5 53.35 5.9
44.0558.4

Aarti Drugs Ltd.

532.1 532 0.02
513.4537

Aayush Food & Herbs Ltd.

47.7 47.9 -0.42
40.152.7

Abbott India Ltd.

4968.65 4861.15 2.21
48505085

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities 68.21
Cash from investing activities -38.34
Cash from financing activities -17.93
Net change in cash 11.95

Stock Held By Mutual Fund Schemes

Cadila bags approval for Minocycline Hydrochloride tablets

Cadila Healthcare Ltd has said that its arm Zydus Pharmaceuticals (USA) Inc. has received the final approval from the USFDA to market Minocycline Hydrochloride Extended - Release Tablets in strengths of 45 mg, 80 mg, 90 mg and 105 mg and 135 mg. Zydus also received the tentative approval for Minocycline Hydrochloride Extended - Release Tablets, 55 mg, 65 mg and 115 mg. “Minocycline Hydrochloride Extended - Release Tablets are a tetracycline-class drug, indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. It will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad,” the company said in a filing to the Bombay Stock Exchange. The group now has more than 170 approvals and has so far filed over 310 ANDAs since the commencement of the filing process in FY 2003-04. Meanwhile, shares of the company were trading at Rs 446.35 apiece, up 0.64 per cent from the previous close at 11:05 hrs on BSE.

24-11-2017 11:01

Revathi Equipment Ltd posts Q2 net profit of Rs 0.27 cr

The company reported standalone net profit during the quarter stood at Rs 0.27 crore compared to net loss of Rs 1.00 crore in the previous year quarter. Net revenue of the company declined by 0.46 per cent at Rs 10.81 crore in July-September quarter of this fiscal as against Rs 10.86 crore in the corresponding period last year. During July-September quarter, operating expenses dropped by 8.47 per cent to Rs 9.72 crore from Rs 10.62 crore in year ago period. Other Income dipped by 4.76 per cent at Rs 0.40 crore versus (Sep'16 Rs 0.42 crore). Operating Profit surged by 354.17 per cent to Rs 1.09 crore as against Rs 0.24 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 348.89 per cent in September quarter. Interest declined by 58.05 per cent y-o-y to Rs 0.73 crore, while Taxation increased by 257.14 per cent at Rs 0.33 crore (Sep'16 Rs -0.21 crore).

24-11-2017 10:27

Salasar Techno Q2 net profit jumps 41.61% at Rs 4.05 cr

The company reported standalone net profit of Rs 4.05 crore for the quarter ended September 30, 2017 as compared to Rs 2.86 crore in the same period last year, registering a year-on-year growth of 41.61 per cent. Net revenue of the company rose substantially by 31.30 per cent at Rs 95.22 crore in July-September quarter of this fiscal as against Rs 72.52 crore in the corresponding period last year. During July-September quarter, operating expenses increased by 32.08 per cent to Rs 89.42 crore from Rs 67.70 crore in year ago period. Other Income grew by 20.00 per cent at Rs 0.06 crore versus (Sep'16 Rs 0.05 crore). Operating Profit surged by 20.12 per cent to Rs 5.79 crore as against Rs 4.82 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 8.28 per cent in September quarter. Interest grew by 16.13 per cent y-o-y to Rs 0.36 crore, while Taxation decreased by 29.17 per cent at Rs 1.53 crore (Sep'16 Rs 2.16 crore).

24-11-2017 10:27

Sunil Healthcare Q2 net profit down 53.80% at Rs 0.79 cr

The company reported standalone net profit of Rs 0.79 crore for the quarter ended September 30, 2017 as compared to Rs 1.71 crore in the same period last year, registering a year-on-year decline of 53.80 per cent. Net revenue of the company declined by 5.58 per cent at Rs 22.85 crore in July-September quarter of this fiscal as against Rs 24.20 crore in the corresponding period last year. During July-September quarter, operating expenses dropped by 1.65 per cent to Rs 19.70 crore from Rs 20.03 crore in year ago period. Other Income grew by 11.76 per cent at Rs 0.19 crore versus (Sep'16 Rs 0.17 crore). Operating Profit slipped by 27.08 per cent to Rs 3.15 crore as against Rs 4.32 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 22.86 per cent in September quarter. Interest grew by 0.99 per cent y-o-y to Rs 1.02 crore, while Taxation decreased by 49.28 per cent at Rs 0.35 crore (Sep'16 Rs 0.69 crore).

24-11-2017 10:27

RIL’s arm closes sale of assets to BKV Chelsea

Reliance Industries Limited has said that its arm Reliance Marcellus II, LLC a subsidiary of Reliance Holding USA, Inc. has closed recently announced sale of its interest in certain upstream assets; which were operated by Carrizo Oil & Gas, Inc to BKV Chelsea LLC, an affiliate of Kalnin Ventures. In a transaction announced on October 06, 2017, Reliance agreed to sell its entire working interest in these upstream assets to BKV Chelsea for purchase consideration of USD 126 million with an effective date of April 01, 2017. Additionally, under the definitive documents, a contingent amount of up to USD 11.25 million may be paid to Reliance between years 2018 to 2020 based on certain gas price thresholds being achieved. The transaction closed on November 21, 2017 and Reliance received the purchase consideration subject to usual and customary purchase price adjustments. Meanwhile, shares of the company were trading at Rs 954.95 apiece, up 1.04 per cent from the previous close at 10:05 hrs on BSE.

24-11-2017 10:00

Albert David Ltd - Financial Results Updates

Albert David Limited has informed the Exchange that the Company has adopted Ind-AS for the first time for the financial year 2017-18. Kindly note that as per timeline prescribed in SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016 we propose to hold our Board Meeting for approving financial results for the half year ended September 30, 2017 during the second week of December, 2017.

09-Nov-2017 12:31 PM

Albert David Ltd - Reply to Clarification Sought

ALBERTDAVD:The Exchange had sought clarification from Albert David Limited with respect to announcement dated 30-Oct-2017, regarding Outcome of Board Meeting held on October 30, 2017. This is to inform you that the Board of Directors have decided to shut down the operations of the Company s plant located at Mandideep Unit at Plot No. 2, New Industrial Area No. 2, Mandideep 462046, Dist. Raisen (M.P.).. On basis of above the Company is required to clarify following: 1. Reasons for closure.2. Date of closure or estimated time of closure;3. Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year;4. Date of such binding agreement, if any, entered for sale of such unit/division, if anyThe response of the Company is attached.

01-Nov-2017 04:21 PM

Albert David Ltd - Clarification

ALBERTDAVD:The Exchange has sought clarification from Albert David Limited with respect to announcement dated 30-Oct-2017, regarding Outcome of Board Meeting held on October 30, 2017. This is to inform you that the Board of Directors have decided to shut down the operations of the Company?s plant located at Mandideep Unit at Plot No. 2, New Industrial Area No. 2, Mandideep ? 462046, Dist. Raisen (M.P.).. On basis of above the Company is required to clarify following: 1. Reasons for closure.2. Date of closure or estimated time of closure;3. Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year;4. Date of such binding agreement, if any, entered for sale of such unit/division, if anyThe response of the Company is awaited.

31-Oct-2017 10:49 AM

Albert David Ltd - Outcome of Board Meeting

Albert David Limited has informed the Exchange regarding Outcome of Board Meeting held on October 30, 2017. This is to inform you that the Board of Directors in their meeting held today (commenced at 4:00 PM and concluded at 5:00 PM) have decided to shut down the operations of the Company?s plant located at Mandideep Unit at Plot No. 2, New Industrial Area No. 2, Mandideep ? 462046, Dist. Raisen (M.P.).

30-Oct-2017 05:35 PM

Albert David Ltd - Outcome of Board Meeting

This is to inform you that the Board of Directors in their meeting held today (commenced at 4:00 PM and concluded at 5:00 PM) have decided to shut down the operations of the Company's plant located at Mandideep Unit at Plot No. 2, New Industrial Area No. 2, Mandideep - 462046, Dist. Raisen (M.P.).

30-Oct-2017 05:21 PM

Albert David Ltd - Outcome of Board Meeting

This is to inform you that the Board of Directors in their meeting held today (commenced at 4:00 PM and concluded at 5:00 PM) have decided to shut down the operations of the Company's plant located at Mandideep Unit at Plot No. 2, New Industrial Area No. 2, Mandideep - 462046, Dist. Raisen (M.P.).

30-Oct-2017 05:21 PM

Albert David Ltd - Press Release / Media Release

In terms of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended, we have published Notice in the newspapers as required in the said Rules. We now enclose copies of the newspapers clippings as published today in Business Standard - English (All India) and Aajkaal - Bengali - Kolkata. Please take the same on record.

27-Oct-2017 01:12 PM

Albert David Ltd - Cessation

This is to inform you that Dr. Karunamay Lahiri, a Director of our Company has ceased to be a Director of our Company with effect from 12th October, 2017.

As per communication received from National Stock Exchange, Dr. K. Lahiri had incurred disqualification under section 164(2) of the Companies Act, 2013 and therefore pursuant to section 167(1) of the said Act, his office of directorship is vacated by operation of law.

Accordingly, the Company has filed the necessary Form No. DIR - 12 with the Ministry of Corporate Affairs on 12th October, 2017 around 6:40 PM.

13-Oct-2017 11:16 AM

Corporate Details

About Management

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Registered Office

D - Block, 3rd Floor, Gillander House, Netaji Subhas Road,

033-22302330,22628436,22628456-8492,      033-22258714,

adidavid@dataone.in

http://www.albertdavidindia.com

Registrar Details

Maheshwari Datamatics (P) Ltd.